文献速递创伤骨科关节外科骨质疏松与代谢性骨病

临床衰弱量表是手术治疗的髋部假体周围骨折患者1年死亡率的强预测因素:来自高手术量机构的分析

The Clinical Frailty Scale is a Strong Predictor of 1-Year Mortality in Surgically Managed Hip Periprosthetic Fracture: An Analysis From a High-Volume Institution.
PubMed 文献 · J Arthroplasty · 2023-11-10

该回顾性研究纳入2008年1月至2021年1月共282例手术治疗的髋部假体周围骨折患者,平均年龄79岁。临床衰弱量表(CFS)与3个月死亡率(比值比2.23,P<0.001)和1年死亡率(比值比2.01,P<0.001)显著相关。CFS预测1年死亡的AUC为0.80,高于美国麻醉医师协会评分(0.68)和年龄校正Charlson合并症指数(0.72)。

要点

  • CFS与手术治疗的髋部假体周围骨折患者3个月死亡率(比值比2.23,P<0.001)和1年死亡率(比值比2.01,P<0.001)显著相关。
  • CFS预测1年死亡的AUC为0.80,高于美国麻醉医师协会评分(0.68)和年龄校正Charlson合并症指数(0.72)。
  • 该组患者1年死亡率为15.7%,需手术治疗的并发症发生率为19.5%,平均住院日8.9±7天。

核心结论

  • 衰弱是一种与手术治疗的髋部假体周围骨折后死亡风险增加相关的综合征。
  • 作者认为CFS可在入院时轻松评估,可作为1年死亡率的强而可靠的预测因素,其AUC高于常规使用的美国麻醉医师协会评分。

研究设计与样本

  • 回顾性研究,分析2008年1月至2021年1月前瞻性收集的数据。
  • 共纳入282例手术治疗的髋部假体周围骨折患者,平均年龄79岁(范围42至106岁)。

主要发现

  • 3个月死亡率为7.8%,1年死亡率为15.7%。
  • 需手术治疗的并发症发生率为19.5%,平均住院日为8.9±7天。
  • CFS与3个月死亡率显著相关(比值比2.23,P<0.001),与1年死亡率显著相关(比值比2.01,P<0.001)。
  • 预测1年死亡率的受试者工作特征曲线下面积:CFS为0.80,美国麻醉医师协会评分为0.68,年龄校正Charlson合并症指数为0.72。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hip periprosthetic fractures (PPFs) after primary total hip arthroplasty are increasing with the number of primary implants and aging population. Mortality has been reported up to 34% at 1-year. The aim of this study was to evaluate the association of Clinical Frailty Scale (CFS) and 1-year mortality, complication rate, and length of stay (LOS) in surgically managed hip PPFs. METHODS: This was a retrospective study of prospectively collected data from January 2008 to January 2021. A total of 282 surgically managed hip PPFs were identified. Mean age was 79 years (range, 42 to 106). Preoperative scores were analyzed through linear regression to identify significant association with mortality, complication and LOS. Receiver operating characteristic curve and Area Under the Curve (AUC) were generated to evaluate the quality of the models and the discriminatory ability of each clinical score. Significance was considered at P values < .05. RESULTS: Mortality was 7.8% at 3-months and 15.7% at 1-year. Complication rate requiring surgery was 19.5% and mean LOS was 8.9 ± 7 days. The CFS was significantly associated with 3-month (odds ratio 2.23, P < .001) and 1-year mortality (odds ratio 2.01, P < .001). The receiver operating characteristic curve test for 1-year mortality showed a greater AUC for the CFS when compared with American Society for Anesthesiologists score and age-adjusted Charlson Comorbidity Index (AUC 0.80 versus 0.68 versus 0.72, respectively). CONCLUSIONS: Frailty is a syndrome with increased risk of mortality after surgically managed PPF. The CFS can be easily assessed at the time of admission and could be considered as a strong and reliable predictor of 1-year mortality with a greater AUC than the conventionally used American Society for Anesthesiologists score.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Mancino F, Wall B, Bucher TA, et al. The Clinical Frailty Scale is a Strong Predictor of 1-Year Mortality in Surgically Managed Hip Periprosthetic Fracture: An Analysis From a High-Volume Institution. J Arthroplasty. 2023. PMID: 37952739. doi:10.1016/j.arth.2023.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。